FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:263-264 July 27, 1995 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

By Giovanni Maciocia. 924 pp. New York, Churchill Livingstone, 1994. $110. ISBN 0-443-043051.

The National Institutes of Health Office of Alternative Medicine is currently sponsoring nine pilot projects (with grants of $30,000 each) on research involving the use of acupuncture or Chinese herbal medicines. This summer, the Food and Drug Administration (FDA) is expected to decide whether to change the classification of acupuncture needles from class III (investigational) to class II (safe and efficacious) medical devices. Research and clinical data on acupuncture were submitted to the FDA in five areas of application: acute and chronic pain, emesis (associated with chemotherapy or pregnancy), substance abuse, central nervous system damage (paralysis), and chronic obstructive pulmonary . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.